Company / Free Cash Flow
TriSalus Life Sciences, Inc. Free Cash Flow History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$41.2M
FY2025
5-year range
-$51.2M / -$33.0M
FY2023-FY2025
Trend
+19.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -$33M to -$41M over the past 2 years.
Based on SEC 10-K filings.
-$41M in FY2025.
Declined from -$33M to -$41M over the past 2 years.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, free cash flow increased 19.5% year-over-year.
Company context
Key Data Points
- Altman Z-Score -2.11 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$41.2M | +19.5% |
| FY2024 | -$51.2M | -55.2% |
| FY2023 | -$33.0M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026